Bioengineering a highly vascularized matrix for the ectopic transplantation of islets

Islets

Volumn 5, Issue 5, 2013, Pages 216-225

  Ellis, Cara E ^a,b   Vulesevic, Branka ^c   Suuronen, Erik ^c   Yeung, Telford ^a,b   Seeberger, Karen ^a,b   Korbutt, Gregory S ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Cell delivery; Chitosan; Chondroitin; Collagen; Diabetes; Islet transplantation; Vascularization

Indexed keywords

1-ETHYL-3-(3-DIMETHYLAMINOETHYL)CARBODIIMIDE; CHITOSAN; CHONDROITIN SULFATE; COLLAGEN; CROSS LINKING REAGENT; CULTURE MEDIUM; CYANAMIDE; INSULIN; LAMININ; N-HYDROXYSUCCINIMIDE; SUCCINIMIDE DERIVATIVE;

ANGIOGENESIS; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; BIOENGINEERING; CHEMISTRY; CULTURE MEDIUM; GRAFT SURVIVAL; HETEROTOPIC TRANSPLANTATION; MOUSE; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PHYSIOLOGY; PROCEDURES; SECRETION (PROCESS); SWINE; TISSUE CULTURE TECHNIQUE; VASCULARIZATION;

ANIMALS; APOPTOSIS; BIOENGINEERING; CARBODIIMIDES; CHITOSAN; CHONDROITIN SULFATES; COLLAGEN; CROSS-LINKING REAGENTS; CULTURE MEDIA; GRAFT SURVIVAL; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LAMININ; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; SUCCINIMIDES; SWINE; TISSUE CULTURE TECHNIQUES; TRANSPLANTATION, HETEROTOPIC;

EID: 84894463009     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.27175     Document Type: Article

References (38)

1. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355:1318-30; PMID:17005949; http://dx.doi.org/10.1056/NEJMoa061267 (Pubitemid 44465460)
2. Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50:7109; PMID:11289033; http://dx.doi.org/10.2337/diabetes.50.4.710
3. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343:230-8; PMID:10911004; http://dx.doi.org/10.1056/NEJM200007273430401 (Pubitemid 30490390)
4. Street CN, Lakey JRT, Shapiro AMJ, Imes S, Rajotte RV, Ryan EA, Lyon JG, Kin T, Avila J, Tsujimura T, et al. Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes 2004; 53:310714; PMID:15561940; http://dx.doi.org/10.2337/diabetes.53.12.3107
5. Villiger P, Ryan EA, Owen R, O'Kelly K, Oberholzer J, Al Saif F, Kin T, Wang H, Larsen I, Blitz SL, et al. Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant 2005; 5:2992-8; PMID:16303015; http://dx.doi.org/10.1111/j.1600-6143.2005.01108.x (Pubitemid 43923962)
6. Bhargava R, Senior PA, Ackerman TE, Ryan EA, Paty BW, Lakey JR, Shapiro AM. Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes 2004; 53:13117; PMID:15111501; http://dx.doi.org/ 10.2337/diabetes.53.5.1311
7. Markmann JF, Rosen M, Siegelman ES, Soulen MC, Deng S, Barker CF, Naji A. Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? Diabetes 2003; 52:1591-4; PMID:12829620; http://dx.doi.org/10.2337/diabetes.52.7.1591 (Pubitemid 36792444)
8. Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran PF, Solez K, et al.; Belatacept Study Group. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005; 353:770-81; PMID:16120857; http://dx.doi.org/10.1056/NEJMoa050085 (Pubitemid 41215486)
9. Robertson RP. Islet transplantation as a treatment for diabetes a work in progress. N Engl J Med 2004; 350:694-705; PMID:14960745; http://dx.doi.org/10. 1056/NEJMra032425 (Pubitemid 38364628)
10. Deng C, Zhang P, Li F, Griffith M, Ruel M, Suuronen EJ. An injectable collagen-chitosan hydrogel for heart repair. Can J Cardiol 2008;24 (suppl E):Abstract #911.
11. Suuronen EJ, Veinot JP, Wong S, Kapila V, Price J, Griffith M, Mesana TG, Ruel M. Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation 2006; 114(Suppl):I138-44; PMID:16820563; http://dx.doi.org/10.1161/CIRCULATIONAHA.105.001081 (Pubitemid 44297142)
12. Balamurugan AN, Gu Y, Tabata Y, Miyamoto M, Cui W, Hori H, Satake A, Nagata N, Wang W, Inoue K. Bioartificial pancreas transplantation at prevascularized intermuscular space: effect of angiogenesis induction on islet survival. Pancreas 2003; 26:279-85; PMID:12657955; http://dx.doi.org/10.1097/ 00006676-200304000-00012 (Pubitemid 36384161)
13. De Vos P, Hillebrands JL, De Haan BJ, Strubbe JH, Van Schilfgaarde R. Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets. Transplantation 1997; 63:824-30; PMID:9089221; http://dx.doi.org/10.1097/00007890-199703270-00006 (Pubitemid 27150588)
14. Hou YT, Ijima H, Takei T, Kawakami K. Growth factor/heparin-immobilized collagen gel system enhances viability of transplanted hepatocytes and induces angiogenesis. J Biosci Bioeng 2011; 112:26572; PMID:21640648; http://dx.doi.org/10.1016/j.jbiosc.2011.05.003
15. Madhavan K, Belchenko D, Motta A, Tan W, Tan W. Evaluation of composition and crosslinking effects on collagen-based composite constructs. Acta Biomater 2010; 6:1413-22; PMID:19815100; http://dx.doi.org/10.1016/j.actbio.2009.09.028
16. Liang WH, Kienitz BL, Penick KJ, Welter JF, Zawodzinski TA, Baskaran H. Concentrated collagen-chondroitin sulfate scaffolds for tissue engineering applications. J Biomed Mater Res A 2010; 94:1050-60; PMID:20694972
17. Osborne CS, Barbenel JC, Smith D, Savakis M, Grant MH. Investigation into the tensile properties of collagen/chondroitin-6-sulphate gels: the effect of crosslinking agents and diamines. Med Biol Eng Comput 1998; 36:129-34; PMID:9614761; http://dx.doi.org/10.1007/BF02522870 (Pubitemid 28059665)
18. Jalili RB, Moeen Rezakhanlou A, HosseiniTabatabaei A, Ao Z, Warnock GL, Ghahary A. Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal. J Cell Physiol 2011; 226:18139; PMID:21506112; http://dx.doi.org/10.1002/jcp.22515
19. Hosseini-Tabatabaei A, Jalili RB, Hartwell R, Salimi S, Kilani RT, Ghahary A. Embedding islet in a liquid scaffold increases islet viability and function. Can J Diabetes 2013; 37:27-35; PMID:24070745; http://dx.doi.org/10. 1016/j.jcjd.2012.10.011
20. Suuronen EJ, Nakamura M, Watsky MA, Stys PK, Müller LJ, Munger R, Shinozaki N, Griffith M. Innervated human corneal equivalents as in vitro models for nerve-target cell interactions. FASEB J 2004; 18:170-2; PMID:14597567
21. Edamura K, Nasu K, Iwami Y, Ogawa H, Sasaki N, Ohgawara H. Effect of adhesion or collagen molecules on cell attachment, insulin secretion, and glucose responsiveness in the cultured adult porcine endocrine pancreas: a preliminary study. Cell Transplant 2003; 12:439-46; PMID:12911131 (Pubitemid 36919042)
22. Korbutt GS, Elliott JF, Ao Z, Smith DK, Warnock GL, Rajotte RV. Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest 1996; 97:2119-29; PMID:8621802; http://dx.doi.org/10.1172/JCI118649 (Pubitemid 26143967)
23. Cardona K, Korbutt GS, Milas Z, Lyon J, Cano J, Jiang W, Bello-Laborn H, Hacquoil B, Strobert E, Gangappa S, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006; 12:3046; PMID:16501570; http://dx.doi.org/10.1038/nm1375
24. Zhou YF, Liu WZ. Laticiferous canal formation in fruits of Decaisnea fargesii: a programmed cell death process? Protoplasma 2011; 248:683-94; PMID:21058023; http://dx.doi.org/10.1007/s00709-010-0229-2
25. Kuraitis D, Zhang P, Zhang Y, Padavan DT, McEwan K, Sofrenovic T, McKee D, Zhang J, Griffith M, Cao X, et al. A stromal cell-derived factor-1 releasing matrix enhances the progenitor cell response and blood vessel growth in ischaemic skeletal muscle. Eur Cell Mater 2011; 22:109-23; PMID:21892805
26. McEwan K, Padavan DT, Deng C, Vulesevic B, Kuraitis D, Korbutt GS, Suuronen EJ. Tunable collagen hydrogels are modified by the therapeutic agents they are designed to deliver. J Biomater Sci Polym Ed 2011; 23:1467-83; PMID:21771391
27. Duffy GP, McFadden TM, Byrne EM, Gill SL, Farrell E, O'Brien FJ. Towards in vitro vascularisation of collagen-GAG scaffolds. Eur Cell Mater 2011; 21:1530; PMID:21225592
28. Ito T, Itakura S, Todorov I, Rawson J, Asari S, Shintaku J, Nair I, Ferreri K, Kandeel F, Mullen Y. Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function. Transplantation 2010; 89:143845; PMID:20568673; http://dx.doi.org/10.1097/TP. 0b013e3181db09c4
29. Ding Y, Xu D, Feng G, Bushell A, Muschel RJ, Wood KJH. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes 2009; 58:1797-806; PMID:19509016; http://dx.doi.org/10.2337/db09-0317
30. Cavallari G, Olivi E, Bianchi F, Neri F, Foroni L, Valente S, La Manna G, Nardo B, Stefoni S, Ventura C. Mesenchymal stem cells and islet cotransplantation in diabetic rats: improved islet graft revascularization and function by human adipose tissue-derived stem cells preconditioned with natural molecules. Cell Transplant 2012; 21:2771-81; PMID:22472472; http://dx.doi.org/ 10.3727/096368912X637046
31. Yeung TY, Seeberger KL, Kin T, Adesida A, Jomha N, Shapiro AMJ, Korbutt GS. Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS One 2012; 7:e38189; PMID:22666480; http://dx.doi.org/10.1371/ journal.pone.0038189
32. Pileggi A, Molano RD, Ricordi C, Zahr E, Collins J, Valdes R, Inverardi L. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 2006; 81:1318-24; PMID:16699461; http://dx.doi.org/10.1097/01.tp.0000203858.41105.88 (Pubitemid 43804553)
33. Sakurai T, Satake A, Sumi S, Inoue K, Nagata N, Tabata Y, Miyakoshi J. The efficient prevascularization induced by fibroblast growth factor 2 with a collagen-coated device improves the cell survival of a bioartificial pancreas. Pancreas 2004; 28:e70-9; PMID:15084987; http://dx.doi.org/10.1097/00006676- 200404000-00028
34. Stiegler P, Matzi V, Pierer E, Hauser O, Schaffellner S, Renner H, Greilberger J, Aigner R, Maier A, Lackner C, et al. Creation of a prevascularized site for cell transplantation in rats. Xenotransplantation 2010; 17:379-90; PMID:20955294; http://dx.doi.org/10.1111/j.1399-3089.2010.00606.x
35. Wang W, Gu Y, Hori H, Sakurai T, Hiura A, Sumi S, Tabata Y, Inoue K. Subcutaneous transplantation of macroencapsulated porcine pancreatic endocrine cells normalizes hyperglycemia in diabetic mice. Transplantation 2003; 76:2906; PMID:12883181; http://dx.doi.org/10.1097/01. TP.0000073613.25658.4D
36. Kin T, Korbutt GS, Rajotte RV. Survival and metabolic function of syngeneic rat islet grafts transplanted in the omental pouch. Am J Transplant 2003; 3:281-5; PMID:12614282; http://dx.doi.org/10.1034/j.1600-6143.2003.00049.x (Pubitemid 36407045)
37. Ao Z, Matayoshi K, Lakey JRT, Rajotte RV, Warnock GL. Survival and function of purified islets in the omental pouch site of outbred dogs. Transplantation 1993; 56:524-9; PMID:8212144; http://dx.doi.org/10.1097/ 00007890-199309000-00007 (Pubitemid 23293009)
38. Yasunami Y, Lacy PE, Finke EH. A new site for islet transplantation-a peritoneal-omental pouch. Transplantation 1983; 36:181-2; PMID:6410557; http://dx.doi.org/10.1097/00007890-198308000-00014 (Pubitemid 13036027)